Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (73)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ivanchuk, S. M.
Right arrow Articles by Mulligan, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ivanchuk, S. M.
Right arrow Articles by Mulligan, L. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 5, 2023-2026, Copyright © 1996 by Oxford University Press

ARTICLES

De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease

SM Ivanchuk, SM Myers, C Eng and LM Mulligan
Department of Pathology, Queen's University, Kingston, ON, Canada.

Hirschsprung disease (HSCR) is a common congenital abnormality characterized by absence of the enteric ganglia in the hind gut. In 10- 40% of HSCR cases, mutations of the RET receptor tyrosine kinase have been found. The recent identification of a multimeric RET ligand/receptor complex suggested that mutations of genes encoding other components of this complex might also occur in HSCR. To investigate this role, we examined the gene for glial cell line-derived neurotrophic factor (GDNF), the circulating ligand of the RET receptor complex, for mutations in a panel of sporadic and familial HSCR. We identified GDNF sequence variants in 2/36 HSCR patients. The first of these was a conservative change which did not affect the GDNF protein sequence. The second variant was a de novo missense mutation in a family with no history of HSCR and without mutation of the RET gene. Thus, our data are consistent with a causative role for GDNF mutations in some HSCR cases.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Med. Genet.Home page
J Amiel, E Sproat-Emison, M Garcia-Barcelo, F Lantieri, G Burzynski, S Borrego, A Pelet, S Arnold, X Miao, P Griseri, et al.
Hirschsprung disease, associated syndromes and genetics: a review
J. Med. Genet., January 1, 2008; 45(1): 1 - 14.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
G. A. Smolen, B. J. Schott, R. A. Stewart, S. Diederichs, B. Muir, H. L. Provencher, A. T. Look, D. C. Sgroi, R. T. Peterson, and D. A. Haber
A Rap GTPase interactor, RADIL, mediates migration of neural crest precursors
Genes & Dev., September 1, 2007; 21(17): 2131 - 2136.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Vargas-Leal, R. Bruno, T. Derfuss, M. Krumbholz, R. Hohlfeld, and E. Meinl
Expression and Function of Glial Cell Line-Derived Neurotrophic Factor Family Ligands and Their Receptors on Human Immune Cells
J. Immunol., August 15, 2005; 175(4): 2301 - 2308.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Garcia-Barcelo, M.-H. Sham, W.-S. Lee, V. C.-H. Lui, B. L.-S. Chen, K. K.-Y. Wong, J. S.-W. Wong, and P. K.-H. Tam
Highly Recurrent RET Mutations and Novel Mutations in Genes of the Receptor Tyrosine Kinase and Endothelin Receptor B Pathways in Chinese Patients with Sporadic Hirschsprung Disease
Clin. Chem., January 1, 2004; 50(1): 93 - 100.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
S Borrego, R M Fernandez, H Dziema, A Niess, M Lopez-Alonso, G Antinolo, and C Eng
Investigation of germline GFRA4 mutations and evaluation of the involvement of GFRA1, GFRA2, GFRA3, and GFRA4 sequence variants in Hirschsprung disease
J. Med. Genet., March 1, 2003; 40(3): e18 - 18.
[Full Text] [PDF]

Home page
 J. Med. Genet.Home page
G Fitze, E Paditz, M Schlafke, E Kuhlisch, D Roesner, and H K Schackert
Association of germline mutations and polymorphisms of the RET proto-oncogene with idiopathic congenital central hypoventilation syndrome in 33 patients
J. Med. Genet., February 1, 2003; 40(2): e10 - 10.
[Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. Eketjall and C. F. Ibanez
Functional characterization of mutations in the GDNF gene of patients with Hirschsprung disease
Hum. Mol. Genet., February 1, 2002; 11(3): 325 - 329.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
J. Amiel and S. Lyonnet
Hirschsprung disease, associated syndromes, and genetics: a review
J. Med. Genet., November 1, 2001; 38(11): 729 - 739.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
M. Bahuau, A. Pelet, D. Vidaud, T. Lamireau, B. Le Bail, A. Munnich, M. Vidaud, S. Lyonnet, and D. Lacombe
GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotype
J. Med. Genet., September 1, 2001; 38(9): 638 - 643.
[Full Text] [PDF]

Home page
 J. Med. Genet.Home page
V. PINGAULT, N. BONDURAND, N. LEMORT, M. SANCANDI, I. CECCHERINI, J.-P. HUGOT, P.-S. JOUK, and M. GOOSSENS
A heterozygous endothelin 3 mutation in Waardenburg-Hirschsprung disease: is there a dosage effect of EDN3/EDNRB gene mutations on neurocristopathy phenotypes?
J. Med. Genet., March 1, 2001; 38(3): 205 - 209.
[Full Text]

Home page
 J. Med. Genet.Home page
J. R Hansford and L. M Mulligan
Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis
J. Med. Genet., November 1, 2000; 37(11): 817 - 827.
[Abstract] [Full Text]

Home page
 J. Med. Genet.Home page
C. Scharfe, M. Hauschild, T. Klopstock, A. J M Janssen, P. H Heidemann, T. Meitinger, and M. Jaksch
A novel mutation in the thiamine responsive megaloblastic anaemia gene SLC19A2 in a patient with deficiency of respiratory chain complex I.
J. Med. Genet., September 1, 2000; 37(9): 669 - 673.
[Abstract] [Full Text]

Home page
 J. Med. Genet.Home page
S. Borrego, A. Ruiz, M. E. Saez, O. Gimm, X. Gao, M. López-Alonso, A. Hernández, F. A Wright, G. Antiñolo, and C. Eng
RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease
J. Med. Genet., August 1, 2000; 37(8): 572 - 578.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Bolk, A. Pelet, R. M. W. Hofstra, M. Angrist, R. Salomon, D. Croaker, C. H. C. M. Buys, S. Lyonnet, and A. Chakravarti
A human model for multigenic inheritance: Phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus
PNAS, January 4, 2000; 97(1): 268 - 273.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
S. M Myers, R. Salomon, A. Goessling, A. Pelet, C. Eng, A. von Deimling, S. Lyonnet, and L. M Mulligan
Investigation of germline GFRalpha -1 mutations in Hirschsprung disease
J. Med. Genet., March 1, 1999; 36(3): 217 - 220.
[Abstract] [Full Text]

Home page
 DevelopmentHome page
S Taraviras, C. Marcos-Gutierrez, P Durbec, H Jani, M Grigoriou, M Sukumaran, L. Wang, M Hynes, G Raisman, and V Pachnis
Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system
Development, January 6, 1999; 126(12): 2785 - 2797.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Borrego, C. Eng, B. Sánchez, M.-E. Sáez, E. Navarro, and G. Antiñolo
Molecular Analysis of the ret and GDNF Genes in a Family with Multiple Endocrine Neoplasia Type 2A and Hirschsprung Disease
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3361 - 3364.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
S. Yajima, C.-H. Lammers, S.-H. Lee, Y. Hara, K. Mizuno, and M. M. Mouradian
Cloning and Characterization of Murine Glial Cell-Derived Neurotrophic Factor Inducible Transcription Factor (MGIF)
J. Neurosci., November 15, 1997; 17(22): 8657 - 8666.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. Widenfalk, C. Nosrat, A. Tomac, H. Westphal, B. Hoffer, and L. Olson
Neurturin and Glial Cell Line-Derived Neurotrophic Factor Receptor-beta (GDNFR-beta ), Novel Proteins Related to GDNF and GDNFR-alpha with Specific Cellular Patterns of Expression Suggesting Roles in the Developing and Adult Nervous System and in Peripheral Organs
J. Neurosci., November 1, 1997; 17(21): 8506 - 8519.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. J. Marsh, Z. Zheng, A. Arnold, S. D. Andrew, D. Learoyd, A. Frilling, P. Komminoth, H. P.H. Neumann, B. A.J. Ponder, B. J. Rollins, et al.
Mutation Analysis of Glial Cell Line-Derived Neurotrophic Factor, a Ligand for an RET/Coreceptor Complex, in Multiple Endocrine Neoplasia Type 2 and Sporadic Neuroendocrine Tumors
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3025 - 3028.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.